Endo Pharmaceuticals Inc
General
Total Cases166
Active Cases5
Patents167
Ratings
Experience
Grade
Trend
DCT
L5
E
PTAB
L5
E
CAFC
L5
B
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/02/25 | SUMMONS ISSUED as to GLAND PHARMA LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | SUMMONS ISSUED as to GLAND PHARMA LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | AO120 Patent/Trademark Form filed. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | AO120 Patent/Trademark Form filed. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | AO120 Patent/Trademark Form filed. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | AO120 Patent/Trademark Form filed. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | Magistrate Judge Rukhsanah L. Singh added. (dmr3) (Entered: 01/02/2025) | |
| 01/02/25 | Magistrate Judge Rukhsanah L. Singh added. (dmr3) (Entered: 01/02/2025) | |
| 12/31/24 | Corporate Disclosure Statement by ENDO USA, INC., ENDO OPERATIONS LIMITED identifying Endo, Inc. as Corporate Parent.. (EKINER, KAAN) (Entered: 12/31/2024) | |
| 12/31/24 | Corporate Disclosure Statement by ENDO USA, INC., ENDO OPERATIONS LIMITED identifying Endo, Inc. as Corporate Parent.. (EKINER, KAAN) (Entered: 12/31/2024) |